中国核学会成立于1980年，是在“两弹一星”功勋科学家倡议发起，具有法人资格的全国性、学术性、非营利性的社会团体，是中国科学技术协会的重要组成部分（同年加入），接受民政部的监督管理。倡导献身、创新、求实、协作的精神，旨在促进核科学技术的普及和推广、繁荣和发展。

     近距离治疗、放疗手术机器人以及人工智能/放疗云技术是近年来放疗应用发展最为快速的领域之一。在中国核学会以及各学科专家学者的倡导与支持下，以北京大学第三医院为依托单位，经过组织专家论证，顺利通过中国核学会评估答辩，并正式批准成立“近距离治疗与智慧放疗分会”。

     经过积极的准备工作，分会于2019年9月19日在北京成功举办线上+线下成立大会，并通过选举产生第一届理事会组织架构，标志着分会正式开始运行。

     分会将在中国核学会的领导和支持下，致力于实现以学术为导向，核技术应用为目标，先进放疗技术产品/解决方案为引擎，临床应用实践为核心价值，基于人工智能、大数据、云计算及互联网技术，搭建创新应用服务平台，营造从基层到高端医疗机构的全产业生态链，成为备受尊重的行业引领者。

Founded in 1980, Chinese Nuclear Society (CNS), affiliated the China Association of Science & Technology (CAST), is a national, academic and non-profit social organization with legal personality initiated by the "Two Bombs & One Star" meritorious scientists. It is a key part of the CAST and under the supervision and administration of the Ministry of Civil Affairs.

Brachytherapy, Robotic Radiosurgery and Artificial Intelligence plus cloud-based technology are one of the most rapidly developing areas of clinical application in recent years. With the support and advocacy of CNS and KOLs in radiotherapy nationwide, the 3th Hospital of Peking University initiates this sector, successfully elected and approved through the criteria of CNS, decided to set up "Brachytherapy & Intelligent Radiosurgery Division (BIRD) ". 

19th Sep, 2020, Organized by CNS, BIRD founding conference held in Beijing successfully by Online plus Off-line after enough preparation. During the meeting, the First Board of Management Organization was elected, this marked BIRD kick-off operation formally as a historic milestone.

Under the leadership and support of the CNS, the BIRD will be aiming to implement by App-oriented with the clinical practicality of advanced nuclear/radiotherapy technologies and products, establish an ecological radiotherapy platform focusing on application, innovation, education and research, create core value and drive from basic to high-end users, resulted as a highly respected leader in Radiotherapy Industry worldwide.